{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:18:42Z","timestamp":1787591922690,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T00:00:00Z","timestamp":1547942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ajoc.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T07:30:00Z","timestamp":1548574200000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab"],"prefix":"10.1016","volume":"14","author":[{"given":"Tomona","family":"Hiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-1864","authenticated-orcid":false,"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2019.01.009_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1869-5760-3-49","article-title":"Sympathetic ophthalmia: to the twenty-first century and beyond","volume":"3","author":"Chu","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"10.1016\/j.ajoc.2019.01.009_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004397-200040010-00008","article-title":"Postoperative sympathetic ophthalmia","volume":"40","author":"Gasch","year":"2000","journal-title":"Int Ophthalmol Clin"},{"issue":"2-3","key":"10.1016\/j.ajoc.2019.01.009_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10792-006-9021-x","article-title":"Vogt-Koyanagi-Harada disease diagnostic criteria","volume":"27","author":"Rao","year":"2007","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajoc.2019.01.009_bib4","first-page":"335","article-title":"Immunological aspects of Behcet's and Vogt-Koyanagi-Harada\u2019s disease","volume":"101","author":"Ohno","year":"1981","journal-title":"Trans Ophthalmol Soc UK"},{"issue":"5","key":"10.1016\/j.ajoc.2019.01.009_bib5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archopht.1995.01100050065032","article-title":"32 cases of sympathetic ophthalmia. A retrospective study at the National Eye institute, Bethesda,Md., from 1982 to 1992","volume":"113","author":"Chan","year":"1995","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2019.01.009_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bjo.84.3.259","article-title":"Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland","volume":"84","author":"Kilmartin","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2019.01.009_bib7","first-page":"5303","article-title":"Efficacy and safety of TNF-\u03b1 inhibitors in non-infectious uveitis: a multicentre retrospective study","volume":"55","author":"Garnier","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2019.01.009_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajoc.2019.01.009_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2019.01.009_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0161-6420(80)35270-6","article-title":"Sixty-five years of sympathetic ophthalmia: a clinicopathologic review of 105 cases (1913 to 1978)","volume":"87","author":"Lubin","year":"1980","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2019.01.009_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/exer.2000.0893","article-title":"Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats","volume":"71","author":"Kondo","year":"2000","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajoc.2019.01.009_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3083.1992.tb01645.x","article-title":"Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation","volume":"11","author":"Palexas","year":"1992","journal-title":"Scand J Immunol Suppl"},{"key":"10.1016\/j.ajoc.2019.01.009_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000055677","article-title":"Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis","volume":"33","author":"Santos","year":"2001","journal-title":"Ophthalmic Res"},{"issue":"2","key":"10.1016\/j.ajoc.2019.01.009_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/archophthalmol.2010.358","article-title":"Successful treatment of refractory sympathetic ophthalmia in a child with infliximab","volume":"129","author":"Gupta","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2019.01.009_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jcrs.2012.02.026","article-title":"Bilateral uveitis after phakic intraocular lens implantation and management with adalimumab","volume":"38","author":"Soheilian","year":"2012","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"10.1016\/j.ajoc.2019.01.009_bib16","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamaophthalmol.2014.426","article-title":"Adalimumab for pediatric sympathetic ophthalmia","volume":"132","author":"Kase","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajoc.2019.01.009_bib17","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.39667","article-title":"French Uveitis Network.Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis","volume":"68","author":"Vallet","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajoc.2019.01.009_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","article-title":"Prevention of flare recurrence in childhood-refractory chronic uveitis: an open label comparative study of adalimumab versus infliximab","volume":"63","author":"Simonini","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.ajoc.2019.01.009_bib19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993618301257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993618301257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:57:20Z","timestamp":1762527440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993618301257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":19,"alternative-id":["S2451993618301257"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2019.01.009","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}